Dr Stacey Richardson Dr Rebecca Hill Dr Christopher Kui Dr Janet Lindsey Dr Yura Grabovska et al. | Emergence and maintenance of actionable genetic drivers at medulloblastoma relapse | 2022 |
|
Dr Maria Lastowska Hani Al-Afghani Haya AL-Balool Harsh SHETH Dr Jonathan Coxhead et al. | Identification of a neuronal transcription factor network involved in medulloblastoma development | 2013 |
|
Dr Katrina Wood Dr Michael Jackson Dr Maria Lastowska Dr Darroch Hall Dr Helen Imrie et al. | Histological profile of tumours from MYCN transgenic mice | 2008 |
|
Dr Maria Lastowska Dr Michael Jackson
| Minimal disease monitoring by QRT–PCR: guidelines for identification and systematic validation of molecular markers prior to evaluation in prospective clinical trials | 2008 |
|
Dr Maria Lastowska Dr Michael Jackson
| Cell lines from MYCN transgenic murine tumours reflect the molecular and biological characteristics of human neuroblastoma | 2007 |
|
Dr Maria Lastowska Dr Mauro Santibanez Koref Ilka Wappler Dr Heiko Peters Dr Andrew Hall et al. | Identification of candidate genes involved in neuroblastoma progression by combining genomic and expression microarrays with survival data | 2007 |
|
Dr Maria Lastowska
| Unequivocal delineation of clinicogenetic subgroups and development of a new model for improved outcome prediction in neuroblastoma | 2005 |
|
Dr Maria Lastowska Professor Andrew Pearson Dr Michael Jackson
| Regions Syntenic to Human 17q Are Gained in Mouse and Rat Neuroblastoma | 2004 |
|
Dr Maria Lastowska Simon Cotterill Natalie Bown Professor John Lunec Professor Tom Strachan et al. | Breakpoint position on 17q identifies the most aggressive neuroblastoma tumors | 2002 |
|
Dr Maria Lastowska
| Comparative genomic hybridization (CGH) analysis of stage 4 neuroblastoma reveals high frequency of 11q deletion in tumors lacking mycn amplification | 2001 |
|
Dr Maria Lastowska Simon Cotterill Dr Nicholas Bown Dr Katia Mazzocco Professor Andrew Pearson et al. | Comprehensive genetic and histopathologic study reveals three types of neuroblastoma tumors | 2001 |
|
Dr Maria Lastowska Dr Nicholas Bown Professor John Lunec Professor Tom Strachan Professor Andrew Pearson et al. | Molecular cytogenetic definition of 17q translocation breakpoints in neuroblastoma | 2001 |
|
Dr Maria Lastowska Dr Nicholas Bown Professor John Lunec Professor Tom Strachan Professor Andrew Pearson et al. | Molecular cytogenetic definition of 17q translocation breakpoints in neuroblastoma | 2001 |
|
Dr Maria Lastowska Dr Nicholas Bown Professor Andrew Pearson
| Multicentre analysis of patterns of DNA gains and losses in 204 neuroblastoma tumors: How many genetic subgroups are there? | 2001 |
|
Dr Seamus O'Neill Dr Maria Lastowska
| MYCN amplification and 17q in neuroblastoma: Evidence for structural association | 2001 |
|
Julie Freeman-Edward Dr Seamus O'Neill Dr Maria Lastowska Nicola Brown
| Expulsion of amplified MYCN from neuroblastoma tumor cells | 2000 |
|
Dr Nicholas Bown Simon Cotterill Dr Maria Lastowska Dr Seamus O'Neill Professor Andrew Pearson et al. | Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma | 1999 |
|
Dr Maria Lastowska Dr Nicholas Bown Professor John Lunec Professor Tom Strachan Professor Andrew Pearson et al. | Molecular cytogenetic delineation of 17q translocation breakpoints in neuroblastoma cell lines | 1998 |
|
Dr Maria Lastowska Professor Andrew Pearson Dr John Wolstenholme Dr Nicholas Bown
| Promiscuous translocations of chromosome arm 17q in human neuroblastomas | 1997 |
|